Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02627495 · ClinicalTrials.gov registry record

Predicting Pain Response to Transcranial Direct Current Stimulation for Phantom Limb Pain in Limb Amputees

A clinical trial of Phantom Limb Pain, sponsored by Spaulding Rehabilitation Hospital.

Completed
Registry status
9
Enrollment target
1
Study location

NCT02627495 is a study of Phantom Limb Pain that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 9 participants, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02627495, a study of Phantom Limb Pain, has completed, sponsored by Spaulding Rehabilitation Hospital.

COMPLETED
Registry status
9 participants
Enrollment target
1
Study location

Study Summary

This study explores the effects transcranial Direct Current Stimulation (tDCS, Soterix ©) on Phantom Limb Pain for patients experiencing chronic phantom limb pain in open-label study design.

Conditions Studied

Interventions

  • DEVICE transcranial Direct Current Stimulation (tDCS): (Soterix ©)

Study Locations (1)

Massachusetts

  • Spaulding Rehabilitation Hospital - Boston

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2015-12-01
Est. Completion 2021-03-09

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

What the Registry Record Tells You About NCT02627495

The ClinicalTrials.gov registry entry for NCT02627495 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (93% lower). The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Phantom Limb Pain appearing as the primary indexed condition, and to 1 intervention - of which transcranial Direct Current Stimulation (tDCS): (Soterix ©) is the first listed.

NCT02627495 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02627495 about?

NCT02627495 is a clinical study titled "Predicting Pain Response to Transcranial Direct Current Stimulation for Phantom Limb Pain in Limb Amputees". This study explores the effects transcranial Direct Current Stimulation (tDCS, Soterix ©) on Phantom Limb Pain for patients experiencing chronic phantom limb pain in open-label study design.

What is the current status of trial NCT02627495?

This trial is currently completed. The enrollment target is 9 participants. The study started on 2015-12-01. Estimated completion is 2021-03-09.

What conditions does trial NCT02627495 study?

This clinical trial studies the following conditions: Phantom Limb Pain.

What interventions are being tested in trial NCT02627495?

The interventions under investigation include: transcranial Direct Current Stimulation (tDCS): (Soterix ©) (DEVICE).

Who is sponsoring clinical trial NCT02627495?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02627495 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Phantom Limb Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.